Hormone Refractory Prostate Cancer
Links shared publicly online about this topic
Cabazitaxel Increased Survival For Patients With Advanced Hormone-Refractory Prostate Cancer
medicalnewstoday.com — “Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improve” View full resource at medicalnewstoday.com
Most Recently Shared on March 4, 2010 at 6:08 pm By:
Cabazitaxel Increased Survival For Patients With Advanced Hormone-Refractory Prostate Cancer http://mnt.to/3yt5 #pharma #pharmaceutical
Cabazitaxel Effective for Hormone Refractory Prostate Cancer After Failure of Taxotere
professional.cancerconsultants.com — “Cabazitaxel Effective for Hormone Refractory Prostate Cancer After Failure of Taxotere” View full resource at professional.cancerconsultants.com
Most Recently Shared on March 5, 2010 at 3:38 pm By:
Cabazitaxel Effective for Hormone Refractory Prostate Cancer After Failure of ... http://bit.ly/asi3l0
A potential new target for treatment of hormone refractory prostate cancer
physorg.com — “A new study identifies a protein that modifies the androgen receptor (AR) and influences its ability to regulate target genes linked with the progression of prostate cancer. The research, published by Cell Press in the April 7th issue of the journal Cancer Cell, may also drive creation of new strategies ...” View full resource at physorg.com
Most Recently Shared on April 6, 2009 at 8:03 pm By:
A potential new target for treatment of hormone refractory prostate cancer http://tinyurl.com/ckakb8
EMEA Gives Official Scientific Advice On Clinical Phase IIb Efficacy Study Of Inecalcitol In Hormone-refractory Prostate Cancer
medicalnewstoday.com — “Hybrigenics, a bio-pharmaceutical company with a focus on research and development of new cancer treatments and specialized in protein interactions, announced that it has received the official sci” View full resource at medicalnewstoday.com
Most Recently Shared on February 4, 2010 at 3:10 pm By:
EMEA Gives Official Scientific Advice On Clinical Phase IIb Efficacy Study Of Inecalcitol In Hormone-refractory Prosta... http://mnt.to/3xbN
Second-Line Treatment for Metastatic Hormone Refractory Prostate Cancer - Renal and Urology News
renalandurologynews.com — “For the first time, it appears there is a second-line treatment option for men with metastatic hormone refractory prostate cancer.” View full resource at renalandurologynews.com
Most Recently Shared on December 30, 2010 at 6:18 pm By:
Second-Line Treatment for Metastatic Hormone Refractory Prostate Cancer: For the first time, it appears there is... http://bit.ly/eQ5bgH
Cabazitaxel Increased Survival for Patients with Advanced Hormone-Refractory Prostate Cancer | Yacht Vacations & Charters
yachtchartersmagazine.com — “Cabazitaxel Increased Survival for Patients with Advanced Hormone-Refractory Prostate Cancer | Yacht Vacations & Charters” View full resource at yachtchartersmagazine.com
Most Recently Shared on March 3, 2010 at 11:51 pm By:
Cabazitaxel Increased Survival for Patients with Advanced Hormone-Refractory ... http://bit.ly/9XVJ4d
Phase 3 trial: Cabazitaxel improves survival in patients with metastatic hormone-refractory prostate cancer
news-medical.net — “Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.” View full resource at news-medical.net
Most Recently Shared on March 4, 2010 at 4:28 am By:
Phase 3 trial: Cabazitaxel improves survival in patients with metastatic hormone-refractory prostate cancer: Sanof... http://bit.ly/aFfmua
UroToday - Docetaxel in combination with prednisolone for hormone refractory prostate cancer - Abstract
urotoday.com — “Breaking urology news written by urologists for urologists. global leaders in urology provide key conference report coverage and daily articles on top urology headlines.” View full resource at urotoday.com
Most Recently Shared on November 13, 2009 at 8:34 am By:
Docetaxel in combination with prednisolone for hormone refractory prostate ... http://bit.ly/1KtdM
Medical News: FDA Okays First Drug for Hormone-Refractory Prostate Cancer - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the chemotherapy agent cabazitaxel (Jevtana) to be used in conjunction with the steroid prednisone for treatment of hormone-refractory prostate cancer.” View full resource at medpagetoday.com
Most Recently Shared on June 17, 2010 at 10:54 pm By:
FDA Okays First Drug for Hormone-Refractory Prostate Cancer http://bit.ly/aKJd8d
Prostate Cancer Hormone Therapy
webmd.com — “Men with locally advanced prostate cancer treated with radiation need 3 years -- not 6 months -- of difficult hormone therapy, a clinical trial shows.” View full resource at webmd.com
Most Recently Shared on June 12, 2009 at 9:11 pm By:
webMD: Prostate Cancer: Who Needs Chemical Castration? http://tinyurl.com/lzkkyz Full http://tinyurl.com/llq7cr
Urology Article | Prostate Cancer
mdlinx.com — “Combination Therapy with VP16 and Ethinylestradiol for Hormone-Refractory Prostate Cancer: Good Response with Tolerability” View full resource at mdlinx.com
Most Recently Shared on November 2, 2010 at 9:07 am By:
Combination Therapy with VP16 and Ethinylestradiol for Hormone-Refractory Prostate Cancer: Good Response w... http://bit.ly/cfwm5v #urology
Hormonal and Radiation Therapy in Prostate Cancer
onclive.com — “Hormonal and Radiation Therapy in Prostate Cancer” View full resource at onclive.com
Most Recently Shared on April 5, 2011 at 4:48 pm By:
Dr. Sandler from Cedars-Sinai Medical Center on the Combination of Hormonal and Radiation Therapy in Prostate Cancer http://goo.gl/Lx0C9
Hormones and prostate cancer - Saga
saga.co.uk — “Prostate cancer growth is not always driven by testosterone, which is why hormone treatment sometimes fails. Siski Green reports” View full resource at saga.co.uk
Most Recently Shared on August 1, 2011 at 11:02 am By:
Hormones and prostate cancer (Saga): Prostate cancer growth is not always driven by testosterone, which is why h... http://bit.ly/noDhnt
Progenics presents Phase 1 PSMA ADC therapy study data for taxane-refractory prostate cancer at ASCO 2010
news-medical.net — “Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane c” View full resource at news-medical.net
Most Recently Shared on June 8, 2010 at 6:29 pm By:
Genetics News: Progenics presents Phase 1 PSMA ADC therapy study data for taxane-refractory prostate cancer at A... http://buzzup.com/zr0u
Hormonal therapy of prostate cancer - Abstract
urotoday.com — “Hormonal therapy of prostate cancer - Abstract” View full resource at urotoday.com
Most Recently Shared on June 29, 2010 at 8:42 am By:
Hormonal therapy of prostate cancer - Abstract http://bit.ly/dp83o3
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Pharma News
The latest pharma industry news published daily. Articles from research centers, universities and prestigious journals.
-
Prostate Cancer
You just hit the official Twitter Page of Prostate Cancer Community! We have the info you need when it come to Prostate Cancer. Dive in and get connected!
-
FightCancer
Cancer news feed, formerly part of a blog. RSS suggestions welcome.
Advertisement

